Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIT | P10721 | 20/20 | 0.66 |
| ▸ | ABL1 | P00519 | 19/20 | 0.66 |
| ▸ | BCR | P11274 | 4/20 | 0.66 |
| ▸ | ABL2 | P42684 | 16/20 | 0.65 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.65 |
| ▸ | PLK4 | O00444 | 1/20 | 0.65 |
| ▸ | DDX3X | O00571 | 1/20 | 0.65 |
| ▸ | GAK | O14976 | 1/20 | 0.65 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.65 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.65 |
| ▸ | CA12 | O43570 | 1/20 | 0.65 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.65 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.65 |
| ▸ | EGFR | P00533 | 1/20 | 0.65 |
| ▸ | CA1 | P00915 | 1/20 | 0.65 |
| ▸ | CA2 | P00918 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | ALB | P02768 | 1/20 | 0.65 |
| ▸ | RAF1 | P04049 | 1/20 | 0.65 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6041090 | 0.84 | KIT (0.66) | KITABL1BCRABL2PDGFRA | |
| SCHEMBL6041094 | 0.81 | ABL1 (0.45) | KITABL1BCRPDGFRAEGFR | |
| SCHEMBL4841459 | 0.81 | ABL1 (0.84) | KITABL1BCRABL2PDGFRA | |
| SCHEMBL13437239 | 0.81 | ABL1 (0.87) | KITABL1BCRABL2PDGFRA | |
| SCHEMBL6041097 | 0.80 | BMX (0.46) | KITABL1BCRPDGFRAEGFR | |
| SCHEMBL3988406 | 0.80 | ABL1 (0.78) | KITABL1BCRABL2PDGFRA | |
| SCHEMBL11939618 | 0.79 | ABL1 (1.00) | KITABL1BCRABL2PDGFRA | |
| SCHEMBL15201447 | 0.79 | ABL1 (0.87) | KITABL1BCRABL2PDGFRA | |
| SCHEMBL11939498 | 0.79 | ABL1 (0.82) | KITABL1BCRABL2PDGFRA | |
| SCHEMBL24124987 | 0.79 | KIT (0.63) | KITABL1BCRABL2PDGFRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060217404-A1 | Pyridylpyrimidine derivatives as effective compounds against prion infections and prion diseases | GPC BIOTECH FORSCHUNGSGESELLSCHAFT MBH (DE) | 2006-09-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060217404-A1 | Pyridylpyrimidine derivatives as effective compounds against prion infections and prion diseases | PRNP, PPM1D, PPM1F | KIT 4607/4885ABL1 904/4885BCR 1230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.